VC, G., CE, N., CJ, B., & AC, F. (2022). Editorial: Risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' reply. Alimentary pharmacology & therapeutics, 55(9), 1220. https://doi.org/10.1111/apt.16917
Chicago Style (17th ed.) CitationVC, Goodoory, Ng CE, Black CJ, and Ford AC. "Editorial: Risky Business. What Do Sufferers' Perceptions of Risk from Interventions for IBS Really Mean? Authors' Reply." Alimentary Pharmacology & Therapeutics 55, no. 9 (2022): 1220. https://doi.org/10.1111/apt.16917.
MLA (9th ed.) CitationVC, Goodoory, et al. "Editorial: Risky Business. What Do Sufferers' Perceptions of Risk from Interventions for IBS Really Mean? Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 55, no. 9, 2022, p. 1220, https://doi.org/10.1111/apt.16917.